Interferon-γ release assay screening in biologics: safe and reliable, but not perfect
Background Systemic biologic agents can increase the risk of re-activation of latent tuberculosis (TB). Prior to initiation, screening for latent TB using an interferon-γ release assay (IGRA) is recommended. There is concern that false-negative IGRAs may be more likely in this context. Methods This...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2022-11-01
|
Series: | ERJ Open Research |
Online Access: | http://openres.ersjournals.com/content/8/4/00193-2022.full |